Ebola as aerogenic weapon

Notice the underlined part.  If anyone has time and skill, see if the symptoms described here are also found in the current epidemic. There are very few sources of actual symptoms of ebola on the Web and they find their source in the Ministry of Disease (CDC).

NOTE:

Aerosal weaponization:

A paper written by E. Johnson, N. Jaax, J. White, and P. Jahrling of US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland was published in 1995 in the International Journal of Experimental Pathology.

The abstract from the paper, Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus,informs:

The potential of aerogenic infection by Ebola virus was established by using a head-only exposure aerosol system. Virus-containing droplets of 0.8-1.2 microns were generated and administered into the respiratory tract of rhesus monkeys via inhalation. Inhalation of viral doses as low as 400 plaque-forming units of virus caused a rapidly fatal disease in 4-5 days. The illness was clinically identical to that reported for parenteral virus inoculation, except for the occurrence of subcutaneous and venipuncture site bleeding and serosanguineous nasal discharge.

Not sure if this is part of the "except" noted above:  

Immunocytochemistry revealed cell-associated Ebola virus antigens present in airway epithelium, alveolar pneumocytes, and macrophages in the lung and pulmonary lymph nodes; extracellular antigen was present on mucosal surfaces of the nose, oropharynx and airways. Aggregates of characteristic filamentous virus were present within type I pneumocytes, macrophages, and air spaces of the lung by electron microscopy. Demonstration of fatal aerosol transmission of this virus in monkeys reinforces the importance of taking appropriate precautions to prevent its potential aerosol transmission to humans.

Transmission (OSHA):

MODE OF TRANSMISSION: In an outbreak, it is hypothesized that the first patient becomes infected as a result of contact with an infected animal (15). Person-to-person transmission occurs via close personal contact with an infected individual or their body fluids during the late stages of infection or after death (1, 2, 15, 27). Nosocomial infections can occur through contact with infected body fluids due to the reuse of unsterilized syringes, needles, or other medical equipment contaminated with these fluids (1, 2). Humans may be infected by handling sick or dead non-human primates and are also at risk when handling the bodies of deceased humans in preparation for funerals, suggesting possible transmission through aerosol droplets (2, 6, 28). In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated (1, 6, 13). The importance of this route of transmission is not clear. Poor hygienic conditions can aid the spread of the virus (6).

INCUBATION PERIOD: Two to 21 days, more often 4 – 9 days (1, 13, 14).

  Dr. Dan Hoft M.D. Ph.D.  has not seen a documented case of HUMAN aerosol infection, but is concerned about the new outbreak.

Since we are lied to about everything by this dictatorship, one needs to pay attention to reports concerning transmission,  but do not follow any major media reports.